Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan sodium phosphate (Samtas) for perioperative management after pediatric congenital heart surgery
jRCTs031230062Active, not recruiting
- Sponsor
- University of Tsukuba Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tolvaptan in heart failure (HF) and Cardiovascular Malformation (CVM), sponsored by University of Tsukuba Hospital. Started Jun 2023; status: active, not recruiting.
02
Drugs
tolvaptan
03
Conditions
heart failure (HF)Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on jRCTs031230062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230062.